QR678® Neo Biomimetic Peptide for Hair

QR678® Neo is a cutting-edge, science-backed hair restoration therapy designed to address hair loss and promote hair regrowth. Developed by leading clinical scientists, this patented treatment leverages biomimetic polypeptides to mimic natural hair growth factors, making it a revolutionary non-surgical solution for various hair loss conditions.

What is QR678® Neo?

QR678® Neo is a first-in-class therapy that targets the root causes of hair loss. Unlike conventional treatments containing minoxidil or finasteride, QR678® Neo is free of side effects and relies on plant-derived biomimetic peptides to enhance hair follicle nourishment and regeneration.

Key Benefits

  • Arrests hair fall and promotes regrowth.
  • Increases the thickness, density, and coverage of existing hair follicles.
  • Effective for multiple hair loss conditions, including androgenetic alopecia, female pattern baldness, and post-chemotherapy hair loss.
  • Quick, non-invasive procedure with visible results.
  • Safe and devoid of side effects.

How Does QR678® Neo Work?

QR678® Neo delivers biomimetic polypeptides directly to the scalp via microinjections, targeting the dermis and stimulating hair follicles. This promotes the anagen (growth) phase of the hair cycle while reducing hair shedding and thinning.

Treatment Conditions

QR678® Neo effectively addresses:

  • Male and female pattern baldness.
  • Alopecia areata.
  • Hair loss due to PCOS, seborrheic dermatitis, or chemotherapy.
  • Post-COVID hair fall.

Treatment Protocol

  • Session Duration: 10 minutes per session.
  • Recommended Schedule: Typically 8–10 sessions spaced 3–4 weeks apart.
  • Maintenance: Periodic sessions as required.

Why Choose QR678® Neo?

  • Clinically proven results, with over 90% success rate in trials.
  • Patented and regulatory-approved therapy used in 10+ countries.
  • Non-surgical alternative to hair transplant and other invasive treatments.
  • Backed by 13+ published clinical trials demonstrating efficacy.

Success Stories

  • Patients with alopecia areata observed significant hair regrowth after 10 sessions.
  • Post-chemotherapy patients experienced remarkable hair restoration.
  • Visible improvements in hair thickness and density for androgenetic alopecia cases.

Global Recognition

QR678® Neo has been widely recognized and awarded in international conferences such as Cuticon and FADS, earning accolades for its innovative approach to hair restoration.

author avatar
Dr. Jane Yoo Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York. Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech. Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.